You have 9 free searches left this month | to do more
Showing 26 - 50 of
1,807 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
E
Recruiting
  • Lymphoblastic Leukemia
  • Lymphoblastic Lymphoma
  • Atlanta, Georgia
  • +3 more
2021-07-15
Jul 15, 2021
S
Recruiting
  • Acute Lymphoblastic Leukemia
  • Seoul, Daehangno, Jongno-gu, Korea, Republic of
    Seoul National University Hospital
2021-06-15
Jun 15, 2021
N
Completed
  • Peripheral T-cell Lymphoma
  • Singapore, Singapore
    National Cancer Centre Singapore
2021-04-27
Apr 27, 2021
C
Not yet recruiting
  • Small-cell Lung Cancer
  • (no location specified)
2020-12-23
Dec 23, 2020
S
Unknown status
  • SCLC
  • Anlotinib
  • Anlotinib hydrochloride
  • +2 more
  • Shanghai, Shanghai, China
    Shanghai Chest hospital
2020-12-22
Dec 22, 2020
C
Completed
  • Breast Cancer
  • apatinib+oral etoposide
  • Beijing, Beijing, China
    Cancer Institute and Hospital, Chinese Academy of Medical Scienc
2020-12-01
Dec 1, 2020
U
Active, not recruiting
  • Recurrent Hodgkin Lymphoma
  • Refractory Hodgkin Lymphoma
  • Brentuximab Vedotin
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2021-12-29
Dec 29, 2021
V
Terminated
  • Small Cell Lung Carcinoma
  • Durvalumab + Tremelimumab in combination with carboplatin and etoposide
  • Durvalumab in combination with carboplatin and etoposide
  • Omaha, Nebraska
    University of Nebraska Medical Center
2022-02-24
Feb 24, 2022
S
Completed
  • Ovarian Cancer
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
2020-12-03
Dec 3, 2020
F
Recruiting
  • Lung Neoplasm
  • +2 more
  • Camrelizumab combined with Apatinib, Etoposide and Cisplatin
  • Fuzhou, Fujian, China
    The 900th Hospital of Joint Logistic Support Force
2021-02-03
Feb 3, 2021
B
Recruiting
  • Ovarian Sex Cord Stromal Tumor
  • +2 more
  • Jinan, Shandong, China
    Qilu Hospital of Shandong University
2021-10-07
Oct 7, 2021
Z
Recruiting
  • Hemophagocytic Syndrome
  • T/NK-Cell Lymphoma
  • Ruxolitinib, Etoposide, Dexamethasone, Gemcitabine, Pegaspargase, cis-platinum
  • Zhengzhou, Henan, China
    Oncology Department of The First Affiliated Hospital of Zhengzho
2021-08-03
Aug 3, 2021
P
Recruiting
  • Relapsed Solid Tumors
  • +3 more
  • Phoenix, Arizona
  • +7 more
2021-07-06
Jul 6, 2021
B
Recruiting
  • Ovarian Germ Cell Cancer
  • +2 more
  • Jinan, Shandong, China
    Qilu Hospital of Shandong University
2021-10-07
Oct 7, 2021
T
Recruiting
  • Ependymoma
  • +3 more
  • Augusta, Georgia
    Augusta University, Georgia Cancer Center
2022-03-20
Mar 20, 2022
M
Terminated
  • HER-2 Positive Metastatic Breast Cancer
  • Washington, District of Columbia
    Washington Cancer Institute
2020-11-10
Nov 10, 2020
N
Active, not recruiting
  • Breast Cancer
  • Brain Metastases
  • BEEP regimen
  • Kaohsiung, Taiwan
  • +7 more
2021-05-06
May 6, 2021
C
Completed
  • Hodgkin's Disease
  • Non-Hodgkin's Lymphoma
  • New York, New York
    Center for Lymphoid Malignancies at CUMC
2020-11-05
Nov 5, 2020
B
Not yet recruiting
  • Small-cell Lung Cancer
  • New York, New York
    Columbia University Irving Medical Center, Herbert Irving Compre
2021-08-02
Aug 2, 2021